Global Enzyme Immunoassays (EIA) Market Research Report
- Report Code: EN 1000
- Publish Date: Upcoming
The growth of the enzyme immunoassays market is fueled by factors like expanding use of immunoassay tests in cancer, point-of-care in vitro diagnostics, infectious disease testing, therapeutic drug level monitoring, and introduction of novel biomarkers. The long shelf life and ease of use also contributes to the rising acceptance of the ELISA technology in both the academics sector as well as the industry sector. However, the tight R&D budget of pharmaceutical companies, reimbursement challenges, and stringent regulatory approvals are factors that restrain the growth of the enzyme immunoassays market. The introduction of multiple platforms and automated closed systems can pose as threats to the future of enzyme-linked immunoassays.
The report “Global Enzyme immunoassays (EIA) Market” analyzes the market by three segments such as instruments, reagents and applications.
The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. The U.S. commanded the largest share of the Americas enzyme immunoassays market. Germany commanded the largest share of the European enzyme immunoassays market. Japan commanded the largest share of the Asia-Pacific enzyme immunoassays market.
The report also provides an extensive competitive landscaping of companies operating in this market. Key players in the enzyme immunoassays market are Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Beckman Coulter, Inc. (U.S.), bioMérieux (France), Ortho Clinical Diagnostics, Inc. (U.S.), Siemens Healthcare Diagnostics (Germany) & others.
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Customization Options:
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standards and deep dive analysis of the following parameters:
Opportunity Analysis
- Unmet needs, revenue pockets and potential areas for expansion
- Comprehensive review of key component providers, assay providers, sole service providers, complete solution providers
Current and Emerging Products
- Analysis of current and emerging Enzyme Immunoassays (EIA) and immunodiagnostic tests
- Review of current instrumentation technologies
Pricing Trends
- Pricing trend of New high value Immunoassay tests
Product Analysis
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virility and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Alternative Products: Impact analysis
MMM’s Healthcare Decision Making Quadrant It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like Patient dynamics (Patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and Macroeconomic indicators (Number of Hospitals and Orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Applications
4.1 Cancer
4.2 Endocrine disorders
4.3 Cardiovascular Disorders
4.4 Infectious disease
4.5 Auto-immune Diseases
4.6 Blood Disorders
4.7 Bone and Mineral Disorders
4.8 Toxicology Screening
5 By Endusers
5.1 Hospitals
5.2 Medical & Diagnostic Laboratories
5.3 Pharmaceuticals
5.4 Contract Research Organization (CRO)
6 By Types
6.1 Medium Throughput
6.2 Low Throughput
6.3 High Throughput
7 By Geographies
7.1 Americas
7.2 Europe
7.3 Asia-Pacific
7.4 Rest of World
8 By Companies
8.1 Siemens AG Healthcare
8.2 Johnson & Johnson
8.3 BioMérieux
8.4 Abbott Laboratories
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North America Enzyme Immunoassays (EIA) The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. The U.S. commanded the largest share of the Americas enzyme immunoassays market. The report “North American Enzyme immunoassays (EIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. |
Upcoming |
|
|
Europe Enzyme Immunoassays (EIA) The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. Germany commanded the largest share of the European enzyme immunoassays market. The report “European Enzyme immunoassays (EIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. |
Upcoming |
|
|
Asia Enzyme Immunoassays (EIA) The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. Japan commanded the largest share of the Asia-Pacific enzyme immunoassays market. The report “Asian Enzyme immunoassays (EIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. |
Upcoming |
